EGFR and breast cancer: ErbB-2 (HER-2/neu) is a member of the epidermal growth factor receptor (EGFR) family that is often constitutively overexpressed and functions as an oncogene product in a substantial fraction of human breast cancers correlating with more aggressive tumor growth, greater invasiveness, enhanced metastatic potential and increased resistance to therapy [2].